(TSX:PET), MARKHAM, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company“) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, announced today the acceptance by the Toronto Stock Exchange (the “TSX“) of the Company's notice of intention to renew its normal course issuer bid […]
Surrey, British Columbia–(Newsfile Corp. – November 28, 2025) – INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the “Company” or “INEO“) announces that the Company is suspending its previously announced rights offering (the “Rights Offering“). The Company has been advised by the TSX Venture Exchange (the “TSXV“) that the TSXV has withdrawn its conditional approval for
Vancouver, Kelowna, and Delta, British Columbia–(Newsfile Corp. – November 28, 2025) – Investorideas.com, a global news source and expert investing resource covering Telecom, AI and Cybersecurity stocks issues a snapshot looking at how cybersecurity is playing a key role in the telecom sector, featuring IQSTEL Inc. (NASDAQ: IQST), a Global Connectivity, AI and Digital Corporation
Pet Valu Holdings Ltd. Announces Renewal of Normal Course Issuer Bid GlobeNewswire November 28, 2025 MARKHAM, Ontario, Nov. 28, 2025 (GLOBE NEWSWIRE) — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company“) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplies, announced today the acceptance by the Toronto Stock Exchange (the
(TSX-V:HOH), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Nov. 28, 2025 (GLOBE NEWSWIRE) — High Arctic ‎Overseas Holdings Corp. (TSXV: HOH) (“High Arctic Overseas” or the “Corporation”) has released its third
(NYSE:ABBV), SKYRIZI(R) (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada's Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn's disease (CD) and now for ulcerative colitis (UC), supported by evidence from pivotal phase 3 clinical trials including MOTIVATE, ADVANCE, FORTIFY (for CD), and INSPIRE, COMMAND (for UC).1,2 AbbVie concludes letter
NEW YORK CITY, NY / ACCESS Newswire / November 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against WPP Plc ("WPP" or the "Company") (NYSE:WPP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / November 28, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ:SKYE) and certain officers.�� The class action, filed in the United States District Court for the Southern District of California, and docketed under 25-cv-03177,
NEW YORK CITY, NY / ACCESS Newswire / November 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed on behalf of Genius Group Limited ("Genius" or "the Company") (NYSE:GNUS) against Citadel Securities LLC ("Citadel") and Virtu Americas LLC ("Virtu") (together, the
NEW YORK CITY, NY / ACCESS Newswire / November 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against StubHub Holdings, Inc. ("StubHub" or "the Company") (NYSE:STUB) and certain of its officers. Class Definition This lawsuit seeks to recover damages against